October 4, 2007

Use of Placebo-Controls in Life Threatening Diseases


The sponsor plans to apply for FDA approval, in addition to local and European registration. There are approved therapies (surfactants) for this illness (Respiratory Distress Syndrome, or RDS) in those countries where this trial is proposed to take place, and surfactants are even used in some of their hospitals. However, surfactants are completely unavailable to infants at many other hospitals, secondary to rationing or economic limitations.

Click here for Internal FDA Document

Subscribe To Our Newsletter!

Sign up and be the first to find out the latest news and articles about what's going on in the medical field.

You may also like

October 20, 2019

President Barak Obama’s *declared* healthcare reform goal was to cut healthcare costs and ...

Read More
The Impact of Comparative Effectiveness Research

October 17, 2019

A congressional hearing was held on October 16, 2019, to examine the allegations ...

Read More
San Diego VA hospital Medical Research in Violation of Informed Consent
{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}